Longeviti Launches ClearFit AI™, a Brain Ultrasound Interface (BUI) to Advance Platform Solutions for Neurological Disorders
The ClearFit AI integrated platform combines sonolucent implant technology, bedside ultrasound imaging, and artificial intelligence to support the future of postoperative brain visualization.
Longeviti Neuro Solutions, a neurotechnology company focused on advancing innovative solutions that unlock post-operative ultrasound access to the brain, today announced the launch of two strategic initiatives, ClearFit AI™, a Brain Ultrasound Interface (BUI). Together, these technologies create a persistent acoustic interface to the brain, enabling real-time bedside imaging and supporting future advances in AI-assisted neurosurgical care.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260625051733/en/ ClearFit AI, a Brain Ultrasound Interface (BUI).
The ClearFit AI™ platform combines:
